The Division of Hematology and Hematologic Malignancies is pleased to welcome Adam S. DuVall, MD, MPH, who joined the faculty as Associate Professor of Medicine on August 1.
Dr. Elizabeth "Betty" Leibold was honored with the 2026 DOIM Lifetime Achievement Award, recognizing her extraordinary career advancing our understanding of iron metabolism and its role in cancer biology.
Dr. George Rodgers III was recognized with the 2026 DOIM Service to the Department Award for his decades of dedicated service and leadership within the Department of Internal Medicine and...
Exciting news with our division community: Dr. Luis Batista has been appointed to the HCI Presidential Chair in Hematologic Malignancies Research, effective July 1, 2026, through June 30, 2031.
The Division of Hematology & Hematologic Malignancies at Huntsman Cancer Institute and the University of Utah is pleased to welcome faculty member: Veronica Guerra, MD
Tsewang Tashi has secured a research grant from Servier Pharmaceuticals to support a new project focused on improving understanding of acute myeloid leukemia (AML) outcomes among U.S. veterans.
The Utah Amyloidosis Program has been selected as one of only 10 multidisciplinary amyloid centers nationwide to participate in the inaugural amyloidosis initiative led by the American Heart Association (AHA).
The Department of Internal Medicine is proud to announce that Ming Y. Lim, MBBCh, MS, has been inducted as a Fellow of the University of Utah Academy of Health Science...
With expertise and persistence, Dr. Tsewang Tashi helped turn a decade of unanswered symptoms into a life-changing diagnosis for one Salt Lake City woman.
The University of Utah Academy of Health Science Educators welcomes Ming Lim from the Division of Hematology & Hematologic Malignancies as a Fellow of the Academy
Behind every major discovery, new therapy, and improvement in patient care is a sustained commitment to asking important questions and securing the resources needed to answer them. This year, the...
